Taro Pharmaceutical Industries (TARO) Stock Highlights

42.97 | +0%

2024-11-21 03:15:08

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada, Israel, and Other Countries.

Statistics

Range Today

42.89 42.98

Volume Today 241.64K

Range 1 Year

32.67 45.76

Volume 1 Year 11.32M

Range 3 Year

22.89 74.79

Volume 3 Year 21.79M

Range 10 Year

22.89 173

Volume 10 Year 178.87M

Highlights

Market Capitalization 1.62B (small)

Floating Shares 8.09M

Current Price 42.97

Price To Earnings 30.05

Price To Revenue 1.17

Price To Book 0.9

Earnings Per Share 1.43

Payout Ratio 0%

Performance

Latest 0%

1 Month +0.99%

3 Months +1.25%

6 Months +3.12%

1 Year +5.99%

3 Years -41.5%

5 Years -50.4%

10 Years -62.09%

Benchmarks

Market Capitalization

16 / 54

Gross Profits

0 / 39

Total Revenue

20 / 50

Total Rank

17 / 54

Free Cashflow

16 / 54

Performance 5 years

25 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.